NicheBio Focus Hemarina specializes in health product development leveraging the unique properties of the arenicola marina worm haemoglobin, presenting a targeted science-driven value proposition for partnerships in therapeutic and diagnostic product development.

Small Team, Flexible With a lean team (11-50 employees) and a patient-centric mission, Hemarina offers agility for collaborative R&D programs, pilot projects, and fast iteration cycles that can shorten time-to-market for partnered solutions.

Funding Momentum Current funding of 4.8M alongside sub-$1M revenue suggests readiness to scale collaborations, seek co-development deals, and pursue grant-driven or milestone-based partnerships to accelerate product milestones.

Tech Stack Ready Adoption of common tools (iCIMS, WordPress, Shopify, Microsoft 365, Stripe, Vimeo) indicates a modern digital footprint and potential for partner-enabled outreach, e-commerce for consumer-facing health innovations, and streamlined collaboration.

Market Positioning Operating in the research services space with a focus on life-saving patient outcomes positions Hemarina as a potential collaborator for biotech or pharma companies seeking novel biologics or biomaterials, especially in niche haemoglobin-based approaches.